When was estrogen discovered

Many groups reported that high estradiol levels in postmenopausal women were associated with an increased risk of breast cancer , As responses to hormonal therapy were not uniform, a means was needed to predict which patients would respond to the antiestrogens and aromatase inhibitors. Interestingly, these studies demonstrated immediate and quite obvious efficacy of antiestrogens and aromatase inhibitors in a proportion of ER-positive patients Supplemental Fig.

Recent attention has focused on resistance to antiestrogens and aromatase inhibitors in women with breast cancer.

An early focus was on estrogen receptor mutations by Fuqua et al. An interesting mechanism is the emergence of clones of cells with mutations of the ER that render them capable of ligand-independent actions These mutations are generally not present in tumors when initially discovered but are observed in tumors exposed long term to hormonal therapies , presumably through a process of selection.

These observations have led to the more common use of the selective receptor downregulator fulvestrant and the development of new, more potent selective receptor downregulators , The rationale is to eliminate these receptors as a means of abrogating their function. Benign tumors and malignant tumors containing high levels of estrogen can cause gynecomastia as in the Peutz-Jeghers syndrome and hepatocellular carcinoma — Duplication, deletion, and inversion resulting from subchromosomal recombinations result in syndromes of aromatase overexpression , Inactivity of aromatase in women can result in pseudohermaphroditism, hirsutism, and other abnormalities — Many controversies arose with respect to the use of estrogen for treatment of the menopause, and both proponents and opponents expressed strong opinions 57 , 87 , — One controversy is whether estrogens cause or prevent breast cancer.

The mechanism for this is not clearly established but may reflect the proapoptotic effects of estrogens on occult, preexisting tumors — Interestingly, recent preclinical data suggest that the effects of conjugated equine estrogen may differ from those of estradiol Another controversy is whether menopausal hormone therapy causes more benefit than harm in postmenopausal women.

Recent reviews detail in considerable depth the actions of estrogen in women and in men and on brain , heart , , vasculature , , ovaries , bones , skeletal muscle , breast , , , adipose tissue , and reproductive tissue , Studies of these actions in depth are found in the reviews cited above but were beyond the scope of the Clark Sawin Lecture. Research into the various actions of estrogen has advanced rapidly in the past 5 years.

To illustrate this point, the estrogen-related publications in the journal Endocrinology from until the present have been identified and categorized here.

A major focus has been on the effects of estrogen on various aspects of brain function, including gonadotropin regulation, behavior, synaptic function, metabolism, and morphogenesis — Three other areas of emphasis have been bone 98 , , , adrenal — , and ovary — Any history must prioritize the issues raised, and this lecture illustrates this point well.

We left out important effects on the brain, including behavior, gonadotropin regulation, and obsessive compulsive disorder, among others; cardiovascular actions; effects on the immune system; pubertal development; and management of menopause and actions on skeletal muscle.

Finally, we apologize to the key investigators that we have failed to mention because of the time allotted to the lecture, but we refer readers to two reviews written by the coauthors 40 , Disclosure Summary: The authors have nothing to disclose. Albright F , Ellsberg R. Uncharted Seas. Portland, OR : Kalmia Press ; : 3 — Google Scholar. Google Preview. Paulshock BZ. Tutankhamun and his brothers. Familial gynecomastia in the Eighteenth Dynasty. Connell SM.

Aristotle and Galen on sex difference and reproduction: a new approach to an ancient rivalry. Stud Hist Philos Sci. Galanakis E. Apgar score and Soranus of Ephesus. The effect of Soranus of Ephesus 98— on the work of midwives. Women Birth. Temkin O.

Soranus Gynecology. Boylan M. J Hist Biol. Hankinson RJ. The Cambridge Companion to Galen. Kaplowitz PB. Link between body fat and the timing of puberty. Frisch RE , Revelle R. Height and weight at menarche and a hypothesis of menarche.

Arch Dis Child. The height and weight of girls and boys at the time of initiation of the adolescent growth spurt in height and weight and the relationship to menarche. Hum Biol. Frisch RE. Body fat, menarche, fitness and fertility. Hum Reprod. Lorriaux DL. Thomas Wharton — : codifying the glands. In: A Biographical History of Endocrinology.

Gynecology in the nineteenth century: ovariotomy. In: History of Medicine. Gendrin AN. Chapter Bernard C. An Introduction to the Study of Experimental Medicine.

Battey R. Normal ovariotomectomy. Atlanta Medical and Surgical Journal. Knauer E. Ovarian transplantation in rabbits: a preliminary report. Contralb F Gyn.

On ovarian transplantation: labour and normal end of pregnancy after transplantation of ovaries in rabbits. Transplantation of the ovaries: an experimental study.

Archiv F Gyn. Fosbery WH. Severe climacteric flushings successfully treated with ovarian extract. Note on the effects produced on man by subcutaneous injections of a liquid obtained from the testicles of animals.

Nieschlag E , Nieschlag S. Testosterone deficiency: a historical perspective. Asian J Androl. Easterbrook CC. Organo-therapeutics in mental diseases. Miao Sun Si. Santen RJ , Simpson E. Data from: History of estrogen: its purification, structure, synthesis, biologic actions, and clinical implications.

Deposited 26 January Temple R. The science of endocrinology. London, UK: Prion; — Beatson GT. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases.

Trans Med Chir Soc Edinb. Stockwell S. Classics in oncology. George Thomas Beatson, M. CA Cancer J Clin. Clarke MJ. Ovarian ablation in breast cancer, to milestones along hierarchy of evidence from case report to Cochrane review. The hormone of the ovarian follicle: its localization and action in test animals and additional points bearing upon the internal secretion of the ovary. Am J Anat. Allen E , Doisy EA. An ovarian hormone: preliminary report on its localization, extraction and partial purification and action in test animal.

Doisy EA. An autobiography. Annu Rev Biochem. Rohde W. The contributions of Aschheim and Zondek to endocrinology. Pediatr Endocrinol Rev. The crystals of thefollicular ovarian hormone. Proc Soc Exp Biol Med. The preparation of the crystalline follicular ovarian hormone: theelin. J Biol Chem. Butenandt A. The isolation of alpha-dihydrotheelin from human placenta. Characterization of theelol. Simpson E , Santen RJ. Celebrating 75 years of oestradiol. J Mol Endocrinol. Albright F.

The effect of hormones on osteogenesis in man. Recent Prog Horm Res. Studies on ovarian dysfunction. N Engl J Med. The menopause. Forbes AP. Fuller Albright. His concept of postmenopausal osteoporosis and what came of it.

Clin Orthop Relat Res. Sturgis SH , Albright F. The mechanism of estrin therapy in the relief of dysmenorrhea. The metabolic effects of steroid hormones in osteoporosis. J Clin Invest. Wallach S , Henneman PH. J Am Med Assoc. Huggins C. How Charles Huggins made his Nobel prize winning discovery—in his own words: an historic audio recording. Interviewed by Willard Goodwin and Elmer Bell. Critical significance of breast structure in the induction of mammary cancer in the rat.

Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J Exp Med. Mammary cancer induced by a single feeding of polynuclear hydrocarbons, and its suppression. Aromatic influences on the yields of mammary cancers following administration of 7,dimethylbenz a anthracene. Welsch CW. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res. Speroff L. Portland, OR : Arnica Publishing ; Goldzieher JW.

The history of steroidal contraceptive development: the estrogens. Perspect Biol Med. Watkins ED. Colton FB. Fehring RJ. In: Koterski JW, ed. Goldin C , Katz LF. J Polit Econ. Jensen EV. Correlation of estrophilin content of primary mammary cancer to eventual endocrine treatment. Ann Surg. Zondek B. Oesrogenic hormone in the urine of the stallion.

Steinach E , Kun H. Transformation of male sex hormones into a substance with the action of a female hormone. Balthazart J , Ball GF. New insights into the regulation and function of brain estrogen synthase aromatase. Trends Neurosci. Studies on the mechanisms of estrogen biosynthesis. Biochim Biophys Acta. Further stereochemical studies of the catalytic reduction of delta-1,keto steroids with tritium. J Org Chem.

Studies on the mechanism of estrogen biosynthesis. The stereochemistry of hydrogen elimination at C-2 during aromatization. J Am Chem Soc. Stereochemical comparison of aromatization in placental and microbiological systems.

Meyer AS. Acta Endocrinol Copenh. The intermediate steps in the biosynthesis of estrogens from androgens. Biochem Biophys Res Commun. Mechanism of the third oxidative step in the conversion of androgens to estrogens by cytochrome P 19A1 steroid aromatase. History of aromatase: saga of an important biological mediator and therapeutic target.

Endocr Rev. The involvement of human placental microsomal cytochrome P in aromatization. Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. Subcellular distribution of aromatase in human placenta and ovary. Horm Res. Preparation and characterization of polyclonal and monoclonal antibodies against human aromatase cytochrome P PAROM , and their use in its purification.

Arch Biochem Biophys. Pasanen M , Pelkonen O. Solubilization and partial purification of human placental cytochromes P Purification and characterization of aromatase from human placenta.

Muto N , Tan L. Purification of oestrogen synthetase by high-performance liquid chromatography. Two membrane-bound enzymes from the human placenta. J Chromatogr A. Purification and characterization of human placental aromatase cytochrome P Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P and its expression in nonsteroidogenic cells.

Harada N. Cloning of a complete cDNA encoding human aromatase: immunochemical identification and sequence analysis. Cloning and expression of the chicken ovary aromatase P expression of mRNA in tissues of the Sebright and Leghorn chicken. Trans Assoc Am Physicians. The expression of a functional cDNA encoding the chicken cytochrome P arom aromatase that catalyzes the formation of estrogen from androgen. Alternative usage of different poly A addition signals for two major species of mRNA encoding human aromatase P FEBS Lett.

Mol Endocrinol. Isolation of a full-length cDNA encoding mouse aromatase P A detailed molecular model for human aromatase. J Steroid Biochem Mol Biol. A three-dimensional model of aromatase cytochrome P Protein Sci. Mammalian microsomal cytochrome P monooxygenase: structural adaptations for membrane binding and functional diversity.

Mol Cell. Three-dimensional model of the human aromatase enzyme and density functional parameterization of the iron-containing protoporphyrin IX for a molecular dynamics study of heme-cysteinato cytochromes.

A molecular model for the interaction between vorozole and other non-steroidal inhibitors and human cytochrome P 19 P aromatase. Structure—function studies of aromatase and its inhibitors: a progress report. Structural basis for androgen specificity and oestrogen synthesis in human aromatase. Tissue-specific expression of the human aromatase cytochrome P gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. The promoter responsible for expression in adipose tissue is different from that utilized in placenta.

Tissue-specific promoters regulate aromatase cytochrome P gene expression in human ovary and fetal tissues. Organization of the human aromatase p CYP19 gene. Semin Reprod Med. Estrogen hormone biology. Curr Top Dev Biol. The nuclear receptor superfamily: the second decade. Estrogen receptors: new directions in the new millennium.

Molecular basis for gene-specific transactivation by nuclear receptors. Allele-specific chromatin recruitment and therapeutic vulnerabilities of ESR1 activating mutations. Cancer Cell. Mitochondrial estrogen receptors—new insights into specific functions. Trends Endocrinol Metab. Levin ER. Extranuclear steroid receptors are essential for steroid hormone actions. Annu Rev Med.

Klinge CM. Estrogens regulate life and death in mitochondria. J Bioenerg Biomembr. Estrogen signaling in the cardiovascular system.

Nucl Recept Signal. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Hormone action and breast cancer. Cancer Treat Res. Am J Physiol Endocrinol Metab. Translating extranuclear steroid receptor signaling to clinical medicine. Horm Cancer. Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors.

The first commercial preparation of estrogen began as an estrogen complex extracted from placentas called Emmenin, which was used to treat dysmenorrhea. The pharmaceutical company Ayerst, McKennen, and Harrison then developed Emmenin as the first oral female sex hormone. In , an article appeared describing a similar collection of substances from pregnant mare urine PMU. This also fueled the search for a safer delivery system for estrogen.

Most of these can be delivered transdermally or intravaginally. Why is this an advantage? All oral estrogens undergo a first pass through the liver via the portal system before entering the general circulation. This leads to a rise in inflammatory and procoagulant markers with a resultant increased risk of venous thrombosis. Transdermal estrogen significantly reduces these risks by entering the bloodstream directly, bypassing the liver.

Progesterone, which is part of HRT given to decrease uterine cancer risk with estrogen alone, can be given intravaginally, transdermally, or perhaps via intrauterine device ongoing research.

It turns out that women without a uterus in the WHI, who therefore did not need the progesterone component of HRT, did not have a greater risk of cardiovascular accident CVA or myocardial infarction MI. In HRT, natural and synthetic estrogens with or without artificial progesterone control menopause symptoms such as hot flashes, skin and vaginal dryness, and bone loss. However, higher risks of breast cancer, heart attack, blood clots, and other serious threats temper the benefits Women's Health Initiative Steering Committee ; Writing Group for the Women's Health Initiative Investigators Women can tailor treatments by weighing known risks and benefits.

Like all steroid hormones, estrogens produce effects by docking with receptors on the cell's membrane surface or inside the cell in the liquid cytoplasm. Receptor binding triggers different chemical signaling systems depending on receptor location. An estrogen uniting with a surface receptor starts a lightening-fast chemical relay in the cytoplasm that can trigger nitric oxide production, flood the cell with calcium, or initiate hormone release. The proteins drive the cell changes guiding estrogen-controlled growth and development Cato et al.

Estrogens have wide-ranging effects throughout life and in both sexes. Most backboned animals depend on the hormones to control and regulate female development, reproduction, and sex characteristics. Their signals also affect blood fat levels, enzyme production, water and salt balance, bone density and strength, skin and blood vessel elasticity, heart muscle, and brain functions such as memory and sexual and maternal behavior.

In the developing animal, estrogens guide formation of the female reproductive tract - vagina, uterus, ovaries - and external genitals. At puberty, their actions guide the appearance of secondary sex characteristics, such as breast and body hair growth and fat distribution in humans and mammary gland and nipple growth in other mammals. The adolescent bone-growth spurt is fueled, and then halted, by estrogens.

Estrogens secreted from the ovaries fluctuate during the reproductive cycle, which may occur episodically frogs mating in response to rainfall , bi-weekly many marine animals , monthly humans , semi-annually cattle , or even bi-annually elephants.

Estrogen levels rise in response to internal or external cues temperature, moon phase, light cycle, presence of potential mates , stimulating eggs to move from their suspended state since birth to finish maturing.

Because the nursery cells surrounding the eggs make estrogens, hormone levels peak at ovulation, when the ovary releases the egg or eggs. Afterward, levels fall rapidly to restart the cycle. When the human ovaries enter menopause, estrogens stop fluctuating cyclically and fall to low levels.

The adrenal glands and other tissues that convert androgens to estrogens then become the prime, steady source of the hormones. Males need estrogens, too. The hormones influence fertility through the prostate, testis, and other sex tissue and by controlling fluid absorption - too much dilutes sperm and decreases egg fertilization - around the maturing sperm in the epididymis, a coiled structure beneath the testes that stores and transmits sperm Hess et al.

At puberty, estradiol regulates growth hormone and determines final height, as in females, by shutting off bone growth at the growing ends, or ephiphysis, of arm and leg bones. Researchers discovered this off switch after examining a still growing 6-footinch man with an estrogen receptor gene mutation Smith et al. Estrogens can also harm people and animals. Long-term exposure to the hormones can increase the risks of breast, endometrial, and vaginal cancers in women US Department of Health and Human Services Too much estrogen aggravates endometriosis, a painful growth of the uterine lining outside the uterus, while too little estrogen weakens bones osteoporosis.